New research has revealed that the connection between per- and polyfluoroalkyl substances, or PFAS, and kidney damage may be tied to dysregulation of the gut microbiome, which is made up of bacteria and other microorganisms that live in the digestive tract.
Decentralized trials: FDA lays out its thinking in new draft guidance
Avadel Pharmaceuticals notched an FDA approval for narcolepsy drug Lumryz on Monday following a multi-year court battle with Jazz Pharmaceuticals. Jazz was forced to delist
May 3, 2023